FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 62 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $116,004 | +34.5% | 26,127 | 0.0% | 0.20% | +243.9% |
Q2 2023 | $86,219 | +15.8% | 26,127 | 0.0% | 0.06% | +7.5% |
Q1 2023 | $74,462 | -60.9% | 26,127 | 0.0% | 0.05% | -92.0% |
Q4 2022 | $190,205 | -9.9% | 26,127 | 0.0% | 0.66% | -4.2% |
Q3 2022 | $211,000 | +64.8% | 26,127 | 0.0% | 0.69% | +121.0% |
Q2 2022 | $128,000 | -79.3% | 26,127 | 0.0% | 0.31% | -70.5% |
Q1 2022 | $618,000 | +38.3% | 26,127 | +3.4% | 1.07% | +110.7% |
Q4 2021 | $447,000 | -22.3% | 25,280 | +24.0% | 0.51% | -15.7% |
Q3 2021 | $575,000 | +168.7% | 20,388 | 0.0% | 0.60% | +145.9% |
Q2 2021 | $214,000 | -10.8% | 20,388 | 0.0% | 0.24% | -23.5% |
Q1 2021 | $240,000 | +0.4% | 20,388 | 0.0% | 0.32% | -3.0% |
Q4 2020 | $239,000 | +47.5% | 20,388 | 0.0% | 0.33% | +7.2% |
Q3 2020 | $162,000 | -42.3% | 20,388 | +32.5% | 0.31% | -73.4% |
Q2 2020 | $281,000 | +52.7% | 15,388 | 0.0% | 1.15% | +1675.4% |
Q1 2020 | $184,000 | -2.6% | 15,388 | +35.1% | 0.06% | +14.0% |
Q4 2019 | $189,000 | -4.1% | 11,388 | -61.7% | 0.06% | -13.6% |
Q3 2019 | $197,000 | – | 29,700 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |